Accumulation of a recombinant immunotoxin in a tumor in vivo: Fewer than 1000 molecules per cell are sufficient for complete responses

Cancer Research

Volumn 58, Issue 5, 1998, Pages 968-975

  Kreitman, Robert J ^a   Pastan, Ira ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOTOXIN; INTERLEUKIN 2 RECEPTOR; IODINE 125; MONOCLONAL ANTIBODY; PSEUDOMONAS EXOTOXIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; AUTORADIOGRAPHY; BIOACCUMULATION; CANCER IMMUNOTHERAPY; CONTROLLED STUDY; CYTOTOXICITY; DRUG DISTRIBUTION; FEMALE; HUMAN; HUMAN CELL; MOUSE; PRIORITY JOURNAL; RADIOIODINATION; SQUAMOUS CELL CARCINOMA; TUMOR REGRESSION;

ADP RIBOSE TRANSFERASES; ANIMALS; ANTIBODIES, MONOCLONAL; BACTERIAL TOXINS; EXOTOXINS; HUMANS; IMMUNOTOXINS; MICE; MICE, NUDE; NEOPLASMS, EXPERIMENTAL; RECEPTORS, INTERLEUKIN-2; RECOMBINANT FUSION PROTEINS; VIRULENCE FACTORS;

EID: 0032032442     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Frankel, A. E., FitzGerald, D., Siegall, C., and Press, O. W. Advances in immunotoxin biology and therapy: a summary of the Fourth International Symposium on Immunotoxins. Cancer Res., 56: 926-932, 1996.
2. Kreitman, R. J., and Pastan, I. Targeting Pseudomonas exotoxin to hematologic malignancies. Semin. Cancer. Biol., 6: 297-306, 1995.
3. Murphy, J. R., and vanderSpek, J. C. Targeting diphtheria toxin to growth factor receptors. Semin. Cancer Biol., 6: 259-267, 1995.
4. Benhar, I., and Pastan, I. Cloning, expression and characterization of the Fv fragments of the anti-carbohydrate mAbs B1 and B5 as single-chain immunotoxins. Protein Eng., 7: 1509-1515, 1994.
5. Benhar, I., and Pastan, I. Characterization of B1(Fv)PE38 and B1(dsFv)PE38: single-chain and disulfide-stabilized Fv immunotoxins with increased activity that cause complete remissions of established human carcinoma xenografts in nude mice. Clin. Cancer Res., 1: 1023-1029, 1995.
6. Pai, L. H., and Pastan, I. Immunotoxin therapy for cancer. J. Am. Med. Assoc., 269: 78-81, 1993.
7. Benhar, I., Padlan, E. A., Jung, S., Lee, B., and Pastan, I. Rapid humanization of the Fv of monoclonal antibody B3 by using framework exchange of the recombinant immunotoxin B3(Fv)-PE38. Proc. Natl. Acad. Sci. USA, 91: , 1994.
8. Friedman, P. N., McAndrew, S. J., Gawlak, S. L., Chace, D., Trail, P. A., Brown, J. P., and Siegall, C. B. BR96 sFv-PE40, a potent single-chain immunotoxin that selectively kills carcinoma cells. Cancer Res., 53: 334-339, 1993.
9. Batra, J. K., Kasprzyk, P. G., Bird, R. E., Pastan, I., and King, C. R. Recombinant anti-erbB2 immunotoxins containing Pseudomonas exotoxin. Proc. Natl. Acad. Sci. USA, 89: 5867-5871, 1992.
10. Wels, W., Harwerth, I-m., Mueller, M., Groner, B., and Hynes, N. E. Selective inhibition of tumor cell growth by a recombinant single-chain antibody-toxin specific for the erbB-2 receptor. Cancer Res., 52: 6310-6317, 1992.
11. Lorimer, I. A., Keppler-Hafkemeyer, A., Beers, R. A., Pegram, C. N., Bigner, D. D., and Pastan, I. Recombinant immunotoxins specific for a mutant epidermal growth factor receptor: targeting with a single chain antibody variable domain isolated by phage display Proc. Natl. Acad. Sci. USA, 93: 14815-14820, 1996.
12. Lorimer, I. A. J., Wikstrand, C. J., Batra, S. K., Bigner, D. D., and Pastan, I. Immunotoxins that target an oncogenic mutant epidermal growth factor receptor expressed in human tumors. Clin. Cancer Res., 1: 859-864, 1995.
13. Kreitman, R. J., Schneider, W. P., Queen, C., Tsudo, M., FitzGerald, D. J. P., Waldmann, T. A., and Pastan, I. Mik-β1(Fv)-PE40, a recombinant immunotoxin cytotoxic toward cells bearing the β-chain of the IL-2 receptor. J. Immunol., 149: 2810-2815, 1992.
14. Francisco, J. A., Gilliland, L. K., Stebbins, M. R., Norris, N. A., Ledbetter, J. A., and Siegall, C. B. Activity of a single-chain immunotoxin that selectively kills lymphoma and other B-lineage cells expressing the CD40 antigen. Cancer Res., 55: 3099-3104, 1995.
15. Chaudhary, V. K., Queen, C., Junghans, R. P., Waldmann, T. A., FitzGerald, D. J., and Pastan, I. A recombinant immunotoxin consisting of two antibody variable domains fused to Pseudomonas exotoxin. Nature (Lond.), 339: 394-397, 1989.
16. Chaudhary, V. K., Gallo, M. G., FitzGerald, D. J., and Pastan, I. A recombinant single-chain immunotoxin composed of anti-Tac variable regions and a truncated diphtheria toxin. Proc. Natl. Acad. Sci. USA, 87: 9491-9494, 1990.
17. Kreitman, R. J., Chaudhary, V. K., Waldmann, T. A., Hanchard, B., Cranston, B., FitzGerald, D. J. P., and Pastan, I. Cytotoxic activities of recombinant immunotoxins composed of Pseudomonas toxin or diphtheria toxin toward lymphocytes from patients with adult T-cell leukemia. Leukemia (Baltimore), 7: 553-562, 1993.
18. Waldmann, T. A. The interleukin-2 receptor. J. Biol. Chem., 266: 2681-2684, 1991.
19. Hwang, J., FitzGerald, D. J., Adhya, S., and Pastan, I. Functional domains of Pseudomonas exotoxin identified by deletion analysis of the gene expressed in E. coli. Cell, 48: 129-136, 1987.
20. Kreitman, R. J., Batra, J. K., Seetharam, S., Chaudhary, V. K., FitzGerald, D. J., and Pastan, I. Single-chain immunotoxin fusions between anti-Tac and Pseudomonas exotoxin: relative importance of the two toxin disulfide bonds. Bioconj. Chem., 4: 112-120, 1993.
21. Kodaka, T., Uchiyama, T., Ishikawa, T., Kamio, M., Onishi, R., Itoh, K., Hori, T., Uchino, H., Tsudo, M., and Araki, K. Interleukin-2 receptor β-chain (p70-75) expressed on leukemic cells from adult T cell leukemia patients. Jpn. J. Cancer Res., 81: 902-908, 1990.
22. Yagura, H., Tamaki, T., Furitsu, T., Tomiyama, Y., Nishiura, T., Tominaga, N., Katagiri, S., Yonezawa, T., and Tarui, S. Demonstration of high-affinity interleukin-2 receptors on B-chronic lymphocytic leukemia cells: functional and structural characterization. Blut, 60: 181-186, 1990.
23. Kreitman, R. J., and Pastan, I. Recombinant single-chain immunotoxins against T and B cell leukemias, Leukemia Lymphoma, 13: 1-10, 1994.
24. Robb, R. J., Greene, W. C., and Rusk, C. M. Low and high affinity cellular receptors for interleukin 2. J. Exp. Med., 160: 1126-1146, 1984.
25. Reed, M. H., Shapiro, M. E., Milford, E. L., Carpenter, C. B., and Kirkman, R. L. Interleukin 2 receptor expression on peripheral blood lymphocytes in association with renal allograft rejection. Transplantation, 48: 361-366, 1989.
26. Allured, V. S., Collier, R. J., Carroll, S. F., and McKay, D. B. Structure of exotoxin A of Pseudomonas aeruginosa at 3.0 angstrom resolution. Proc. Natl. Acad. Sci. USA, 83: 1320-1324, 1986.
27. Kreitman, R. J., and Pastan, I. Importance of the glutamate residue of KDEL in increasing the cytotoxicity of Pseudumonas exotoxin derivatives and for increased binding to the KDEL receptor Biochem. J., 307: 29-37, 1995.
28. Chiron, M. F., Fryling, C. M., and FitzGerald, D. J. Cleavage of Pseudomonas exotoxin and diphtheria toxin by a furin-like enzyme prepared from beef liver. J. Biol. Chem., 269: 18167-18176, 1994.
29. 280 generates the enzymatically active fragment which translocates to the cytosol. J. Biol. Chem., 267: 25396-25401, 1992.
30. Theuer, C., Kasturi, S., and Pastan, I. Domain II of Pseudomonas exotoxin A arrests the transfer of translocating nascent chains into mammalian microsomes. Biochemistry, 33: 5894-5900, 1994.
31. Theuer, C. P., Buchner, J., FitzGerald, D., and Pastan, I. The N-terminal region of the 37-kDa translocated fragment of Pseudomonas exotoxin A aborts translocation by promoting its own export after microsomal membrane insertion. Proc. Natl. Acad. Sci. USA, 90: 7774-7778, 1993.
32. Kreitman, R. J., Bailon, P., Chaudhary, V. K., FitzGerald, D. J. P., and Pastan, I. Recombinant immunotoxins containing anti-Tac(Fv) and derivatives of Pseudomonas exotoxin produce complete regression in mice of an interleukin-2 receptor-expressing human carcinoma. Blood, 83: 426-434, 1994.
33. Brinkmann, U., Pai, L. H., FitzGerald, D. J., Willingham, M., and Pastan, I. B3(Fv)-PE38KDEL, a single-chain immunotoxin that causes complete regression of a human carcinoma in mice. Proc. Natl. Acad. Sci. USA, 88: 8616-8620, 1991.
34. Webber, K. O., Kreitman, R. J., and Pastan, I. Rapid and specific uptake of anti-Tac disulfide-stabilized Fv by interleukin-2 receptor-bearing tumors. Cancer Res., 55: 318-323, 1995.
35. Sung, C., Dedrick, R. L., Hall, W. A., Johnson, P. A., and Youle, R. J. The spatial distribution of immunotoxins in solid tumors: assessment by quantitative autoradiography. Cancer Res., 53: 2092-2099, 1993.
36. Sung, C., Youle, R. J., and Dedrick, R. L. Pharmacokinetic analysis of immunotoxin uptake in solid tumors: role of plasma kinetics, capillary permeability, and binding. Cancer Res., 50: 7382-7392, 1990.
37. Buchsbaum, D. J., Nelson, L. A., Hanna, D. E., and Vallera, D. A. Human leukemia cell binding and killing by anti-CD5 radioimmunotoxins. Int. J. Radiat. Oncol. Biol. Phys., 13: 1701-1712, 1987.
38. Manske, J. M., Buchsbaum, D. J., Hanna, D. E., and Vallera, D. A. Cytotoxic effects of anti-CD5 radioimmunotoxins on human tumors in vitro and in a nude mouse model. Cancer Res., 48: 7107-7114, 1988.
39. Perkins, A. C., Pimm, M. V., and Baldwin, R. W. Demonstration of the hepatic uptake of radiolabelled immunotoxins using gamma scintigraphy. Eur. J. Cancer Clin. Oncol., 23: 1225-1227, 1987.
40. Byers, V. S., Pimm, M. V., Pawluczyk, I. Z. A., Lee, H. M., Scannon, P. J., and Baldwin, R. W. Biodistribution of ricin toxin A chain-monoclonal antibody 791T/36 immunotoxin and influence of hepatic blocking agents. Cancer Res., 47: 5277-5283, 1987.
41. Skilleter, D. N., Price, R. J., and Thorpe, P. E. Modification of the carbohydrate in ricin with metaperiodate and cyanoborohydride mixtures: effect on binding, uptake and toxicity to parenchymal and non-parenchymal cells of rat liver. Biochem. Biophys. Acta, 842: 12-21, 1985.
42. Fulton, R. J., Tucker, T. F., Vitetta, E. S., and Uhr, J. W. Pharmacokinetics of tumor-reactive immunotoxins in tumor-bearing mice: effect of antibody valency and deglycosylation of the ricin A chain on clearance and tumor localization. Cancer Res., 48: 2618-2625, 1988.
43. Jain, R. K. Delivery of novel therapeutic agents in tumors: physiological barriers and strategies. J. Natl. Cancer Inst., 81: 570-576, 1989.
44. 486IL-2 in animal models. Cancer Chemother. Pharmacol., 26: 409-414, 1990.